SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis

Background: Empagliflozin is a sodium glucose co-transporter 2 (SGLT-2) inhibitor that works in the proximal renal tubules reducing resorption of glucose and increasing urinary glucose excretion. It effectively lowers glycated hemoglobin (HbA1C) values and reduces risks of adverse cardiovascular eve...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Thomas, Mathew, Tran, Ly, White, Christopher, Deppe, John, Davidson, James
Format: Artigo
Language:Inglês
Published: Endocrine Society 2019
Subjects:
Diabetes Mellitus and Glucose Metabolism
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552746/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB030
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items